↓ Skip to main content

Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey

Overview of attention for article published in BMC Infectious Diseases, November 2013
Altmetric Badge

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey
Published in
BMC Infectious Diseases, November 2013
DOI 10.1186/1471-2334-13-560
Pubmed ID
Authors

Stuart J Turner, Esin Senol, Ates Kara, Daoud Al-Badriyeh, Ener C Dinleyici, David CM Kong

Abstract

Invasive fungal infections (IFI) are associated with considerable expense and mortality on healthcare systems. There is a need to provide evidence of both clinical efficacy and value for money with any health technology. The current pharmacoeconomic evaluation investigated the use of liposomal amphotericin B (LAmB) and voriconazole for the empiric treatment of IFI in the Turkish setting.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Sri Lanka 1 2%
Unknown 40 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 17%
Student > Master 6 15%
Other 5 12%
Student > Postgraduate 4 10%
Student > Bachelor 4 10%
Other 5 12%
Unknown 10 24%
Readers by discipline Count As %
Medicine and Dentistry 11 27%
Pharmacology, Toxicology and Pharmaceutical Science 5 12%
Economics, Econometrics and Finance 2 5%
Biochemistry, Genetics and Molecular Biology 1 2%
Business, Management and Accounting 1 2%
Other 6 15%
Unknown 15 37%